TY - JOUR
T1 - Active Surveillance of Grade Group 1 Prostate Cancer
T2 - Long-term Outcomes from a Large Prospective Cohort
AU - Tosoian, Jeffrey J.
AU - Mamawala, Mufaddal
AU - Epstein, Jonathan I.
AU - Landis, Patricia
AU - Macura, Katarzyna J.
AU - Simopoulos, Demetrios N.
AU - Carter, H. Ballentine
AU - Gorin, Michael A.
N1 - Publisher Copyright:
© 2019 European Association of Urology
PY - 2020/6
Y1 - 2020/6
N2 - Men with grade group 1 prostate cancer electing active surveillance are at minimal risk of cancer mortality or metastasis over long-term follow-up. Additional data will characterize the safety of active surveillance in higher-risk patients and better optimize the use of noninvasive testing.
AB - Men with grade group 1 prostate cancer electing active surveillance are at minimal risk of cancer mortality or metastasis over long-term follow-up. Additional data will characterize the safety of active surveillance in higher-risk patients and better optimize the use of noninvasive testing.
KW - Active surveillance
KW - Low-risk prostate cancer
KW - Magnetic resonance imaging
KW - Prostate biopsy
KW - Prostate-specific antigen
KW - Very-low-risk prostate cancer
UR - http://www.scopus.com/inward/record.url?scp=85077377839&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077377839&partnerID=8YFLogxK
U2 - 10.1016/j.eururo.2019.12.017
DO - 10.1016/j.eururo.2019.12.017
M3 - Article
C2 - 31918957
AN - SCOPUS:85077377839
SN - 0302-2838
VL - 77
SP - 675
EP - 682
JO - European Urology
JF - European Urology
IS - 6
ER -